Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
Lowe's Companies
LOW
|
+$520M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$329M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$328M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$283M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$269M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.08B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$253M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$232M |
| 4 |
SPDR S&P Global Natural Resources ETF
GNR
|
+$216M |
| 5 |
VanEck Oil Services ETF
OIH
|
+$192M |
Sector Composition
| 1 | Technology | 17.62% |
| 2 | Healthcare | 10.9% |
| 3 | Financials | 9.91% |
| 4 | Consumer Discretionary | 9.06% |
| 5 | Industrials | 5.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Icon
ICLR
$13.5B
| $6.2M | ﹤0.01% |
33,734
+1,650
| +5% | +$303K |
|
1002
Acadia Pharmaceuticals
ACAD
$4.05B
| $6.2M | ﹤0.01% |
378,730
+114,242
| +43% | +$1.87M |
|
1003
Charles River Laboratories
CRL
$7.76B
| $6.19M | ﹤0.01% |
31,423
+13,001
| +71% | +$2.56M |
|
1004
Tencent Music
TME
$39.5B
| $6.18M | ﹤0.01% |
1,522,062
-819,993
| -35% | -$3.33M |
|
1005
Axon Enterprise
AXON
$58.6B
| $6.17M | ﹤0.01% |
53,315
-11,329
| -18% | -$1.31M |
|
1006
PTC Therapeutics
PTCT
$4.81B
| $6.15M | ﹤0.01% |
122,458
-5,647
| -4% | -$284K |
|
1007
Rivian
RIVN
$17.3B
| $6.15M | ﹤0.01% |
186,781
+113,118
| +154% | +$3.72M |
|
1008
Vir Biotechnology
VIR
$729M
| $6.15M | ﹤0.01% |
318,780
+97,130
| +44% | +$1.87M |
|
1009
ICICI Bank
IBN
$114B
| $6.14M | ﹤0.01% |
292,949
+2,932
| +1% | +$61.5K |
|
1010
Arcus Biosciences
RCUS
$1.23B
| $6.14M | ﹤0.01% |
234,683
+56,183
| +31% | +$1.47M |
|
1011
Range Resources
RRC
$8.3B
| $6.13M | ﹤0.01% |
242,727
+68,882
| +40% | +$1.74M |
|
|
SJI
1012
DELISTED
South Jersey Industries, Inc.
SJI
| $6.12M | ﹤0.01% |
183,002
+10,309
| +6% | +$345K |
|
|
KRTX
1013
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $6.11M | ﹤0.01% |
27,163
-12,986
| -32% | -$2.92M |
|
1014
Goldman Sachs JUST US Large Cap Equity ETF
JUST
$485M
| $6.1M | ﹤0.01% |
119,304
-1,274
| -1% | -$65.2K |
|
1015
Alaska Air
ALK
$7.32B
| $6.1M | ﹤0.01% |
155,842
-50,273
| -24% | -$1.97M |
|
|
NLSN
1016
DELISTED
Nielsen Holdings plc
NLSN
| $6.1M | ﹤0.01% |
219,917
-711,014
| -76% | -$19.7M |
|
1017
HEICO Class A
HEI.A
$35.2B
| $6.09M | ﹤0.01% |
53,145
-3,109
| -6% | -$356K |
|
|
DRAY
1018
DELISTED
Macondray Capital Acquisition Corp. I Class A Ordinary Shares
DRAY
| $6.08M | ﹤0.01% |
+607,014
| New | +$6.08M |
|
1019
Ally Financial
ALLY
$12.8B
| $6.08M | ﹤0.01% |
218,330
-31,316
| -13% | -$872K |
|
1020
Murphy Oil
MUR
$3.66B
| $6.08M | ﹤0.01% |
172,763
+52,636
| +44% | +$1.85M |
|
1021
Thor Industries
THO
$5.77B
| $6.02M | ﹤0.01% |
85,973
+6,589
| +8% | +$461K |
|
1022
Liberty Broadband Class C
LBRDK
$8.66B
| $6M | ﹤0.01% |
81,355
+5,482
| +7% | +$405K |
|
1023
Dynatrace
DT
$14.7B
| $5.99M | ﹤0.01% |
172,124
+51,742
| +43% | +$1.8M |
|
1024
Deckers Outdoor
DECK
$17.4B
| $5.99M | ﹤0.01% |
114,966
+21,132
| +23% | +$1.1M |
|
1025
BioCryst Pharmaceuticals
BCRX
$1.69B
| $5.98M | ﹤0.01% |
474,579
+68,691
| +17% | +$866K |
|